483
Bloomage Biotechnology Corp., Ltd.Bloomage Biotechnology Corp., Ltd. – FDA 483, Apr 26, 2019
Record Details
An FDA inspection of Bloomage Biotechnology Corp., LTD., an API manufacturer in Jinan, China, revealed significant deficiencies in their quality control systems. Observations included failures in quality unit responsibilities regarding chromatographic data review, inadequate analytical method validation, and incomplete laboratory instrument calibration records. Additionally, the firm did not conduct appropriate laboratory tests for raw materials, intermediates, and APIs.
View Company Profile
ID · bbe500a9-bddd-436e-b34a-707edb2d3267
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.